Dergiler / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 5

The effect of neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and mean platelet volume to thrombocyte ratio (MPV/PLT) on survival in myelodysplastyc syndrome

Sayfa
434–438
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: We concluded that NLR and LMR may have a prognostic value for patients who are ≥70 years diagnosed MDS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The aim of the study is to evaluate the relationship between age and leukocyte subtype ratio and their effects on survival in patients diagnosed with myelodysplastic syndrome (MDS).
📊
Temel Bulgular & Veri:Materials and Methods: We retrospectively examined total of 101 patients diagnosed with MDS between January 2010 and June 2020.
💡
Sonuç & Katkı:Conclusion: We concluded that NLR and LMR may have a prognostic value for patients who are ≥70 years diagnosed MDS.
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: The aim of the study is to evaluate the relationship between age and leukocyte subtype ratio and their effects on survival in patients diagnosed with myelodysplastic syndrome (MDS). Materials and Methods: We retrospectively examined total of 101 patients diagnosed with MDS between January 2010 and June 2020. The patients were analysed by dividing into two groups; < 70 years and ≥70 years. Results: The median of overall survival was significantly higher in < 70 years’ group (96 vs 40 month, OR 3.6; 95% CI, 1.6-8.7, p < 0.001). Whereas neutrophil-to-lymphocyte ratio (NLR) was significantly higher in ≥70 years group, lymphocyte-to-monocyte ratio (LMR) was significantly higher in < 70 years group (p = 0,013 and p = 0,041, respectively). NLR was positively correlated with age (rho: 0.27, p = 0.007) but negatively correlated with clinical risk (rho: -0.24, p = 0.018), MPV/PLT ratio was positively correlated with IPSS group (rho: 0.40, p < 0.001). In multivariate analysis, its found that age and IPSS group effects overall survival. HR was 1.064 (95% CI; 1.033-1.096, p < 0.001) for age and was 3.664 (95% CI; 1.285-10.445, p < 0.015) for IPSS group (low versus intermediate-2). Conclusion: We concluded that NLR and LMR may have a prognostic value for patients who are ≥70 years diagnosed MDS.

🔖

Bu Makaleye Atıf Yap

ÇENELİ, Ö., TEKİNALP, A., DEMİRCİOĞLU, S., ÇELİK, A. F. (2022). The effect of neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and mean platelet volume to thrombocyte ratio (MPV/PLT) on survival in myelodysplastyc syndrome. Annals of Medical Research, Cilt: 29 - Sayı: 5, 434–438. https://ajindex.com/articles/446142

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015; 126: 9–16
  2. Abel GA, Efficace F, Buckstein RJ, Tinsley S, Jurcic JG, Martins Y et al. Prospective international validation of the quality of life in myelodysplasia scale (QUALMS). Haematologica. 2016; 101(6): 781-8
  3. Goldberg SL, Chen E, Corral M, Guo A, Mody-Patel N, Pecora AL et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol. 2010;28(17):2847–52
  4. Kuendgen A, Strupp C, Aivado M, Hildebrandt B, Haas R, Gattermann N et al. Myelodysplastic syndromes in patients younger than age 50. J Clin Oncol. 2006;24(34):5358–65
  5. Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G et al. Validation of WHO classificationbased Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla. Leukemia. 2015;29(7):1502–13
  6. Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer. BMC Cancer. 2020;20(1):208
  7. Williamson PJ, Kruger AR, Reynolds PI, Hamblin TJ, Oscier DG. Establishing the incidence of myelodysplastic syndrome. Br J Haematol. 1994;87(4):743–5
  8. Chihara D, Ito H, Katanoda K, Shibata A, Matsuda T, Sobue T et al. Incidence of myelodysplastic syndrome in Japan. J Epidemiol. 2014;24(6):469–73
  9. Wang H, Wang X, Xu X, Lin G. Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: A multicenter study. Ann Hematol. 2010;89(6):535–44
  10. Garcia-Manero G, Shan J, Faderl S, Cortes J, Ravandi F, Borthakur G et al. A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia. 2008;22(3):538–43
  11. Pileggi C, Sanzo M Di, Mascaro V, Marafioti MG, Costanzo FS, Pavia M. Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies. PLoS One. 2017;12(6); e0179016
  12. Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y et al. Prognostic significance of serum ferritin level at dia